Cited by 942Cytokine Signaling Pathways and InteractionsImmunodeficiency and Autoimmune DisordersNF-κB Signaling Pathways

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Open access

O'Shea, John J., Holland, Steven M., Staudt, Louis M.·2013·New England Journal of Medicine

DOI 10.1056/nejmra1202117PMC PMC7604876

Open this paper in CoChat — free account

Abstract

A large number of cytokines signal through the JAK–STAT pathway. Abnormal function of this pathway may lead to a variety of diseases. Targeting the defects in this signaling pathway has already led to treatment advances, and further advances are likely.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra1202117

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M., Miller, C., Silver, R. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110557 · Cited by 2,103
JAKS AND STATS: Biological Implications
Leonard, W. J., & O’Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,826
Self-citation
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110556 · Cited by 1,825
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596

Show all 101 references

Research works printed but not linked: 1

10.1172/JCI0215617 · DOI

Sorted by citations

Items 801–900 of 942

Fascículo 18(2) Completo
Castrillón, J. J. C. (1969) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.18.2.3061.2018
JAK, an Oncokinase in Hematological Cancer
Recio, C., Aranda-Tavío, H., Guerra-Rodríguez, M., de Mirecki-Garrido, M., Martin‐Rodríguez, P., Guerra, B., & Fernández‐Pérez, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84177
Short Stature, Prolonged Fever and Lymphoproliferation
Kanariou, M. G., Tantou, S., & Kotsonis, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21262-9_89
Fungal Infections in the Setting of Biological Therapies (in the Non-Transplant Host)
Lionakis, M. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21022-4
Signal transduction in immune cells
Hanson, E. P., Muallem, D. R., Bonelli, M. M., O’Shea, J. J., & Aringer, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00014-0
Self-citation
Translation of new therapies: From bench to bedside
Sokolove, J. B. (2020) · doi:10.1093/med/9780198831433.003.0038
The state of redox processes and of antiradical protection system in patients with stomach cancer
Vasylieva, I. M., Krasnoselskyi, N. V., Вишницька, І. А., Жуков, В. І., & Denysenko, S. A. (2015) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xix.2.74.2015.68
The importance of homotypic interactions of unphosphorylated STAT proteins in cytokine-induced signal transduction
Menon, P. R. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8488
Dipeptidyl‐peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosis
Kaneko, S., Onda, Y., Sakamoto, S., Okada, M., & Anzai, N. (2021) · eJHaem · doi:10.1002/jha2.229
Ex-Vivo Model for Muscle Exposure to Tumor Cell Conditioned Media
Chahal, I. K. (2018) · doi:10.33915/etd.5330
Comprehensive analysis of expression and prognosis for signal transducer and activator of transcription family in acute myeloid leukemiaPreprint
Qin, T., Shao, Y., & Zhao, H. (2021) · Research Square · doi:10.21203/rs.3.rs-876169/v1
Crustacea (Carotenoids Namely Astaxanthins) Against Cancer
Blundell, R. A., Grech, J. C., & Shah, M. A. (2021) · Food bioactive ingredients · doi:10.1007/978-3-030-74035-1_8
A novel approach in treatment of rheumatoid arthritis: Janus kinase inhibitors
Bhanwra, S., & Ahluwalia, K. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20150013
[Effects of L-asparaginase on proliferation, cell cycle and apoptosis of Burkitt lymphoma cell lines].
Tu, D., Zhang, M., Yin, W. J., Xu, L. Y., Sang, W., Li, Z. Y., & Xu, K. (2021) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2021.11.008
Overactive STAT3 Drives Accumulation of Disease-Associated CD21 low B CellsPreprint
Masle‐Farquhar, E., Peters, T. J., Jackson, K., Singh, M., Ma, C. S., Suan, D., Uzel, G., Chua, I. C., Leiding, J. W., Heiskanen, K., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3996405
Seven Deadly Sins of the Immune System
Rijkers, G. T. (2021) · Journal of Vaccines Immunology and Immunopathology · doi:10.29011/2575-789x.000165
Development of a prognostic model for esophageal cancer based on nine immune related genesPreprint
Zhang, Z., Chen, C., Fang, Y., Li, S., Wang, X., Sun, L., Zhou, G., & Ye, J. (2020) · doi:10.21203/rs.3.rs-47884/v1
Janus Kinases (JAKs)/STAT Pathway
Afzali, B., & John, S. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_36
Mixed T‐ and B‐Lymphocyte Deficiency Disorders
Vihinen, M. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0002167.pub4
Autosomal Dominant Transmission of Signal Transduction and Activator of Transcription 1 (STAT 1) Mutation (Thr385Met) and Extended Lifespan
Wessell, K. R., Tcheurekdjian, H., & Hostoffer, R. (2015) · LymphoSign Journal · doi:10.14785/lymphosign-2015-0013
Vaccine Immunomodulation of Disease: Targeting the Treatment of Autoimmune Diseases
Rosenthal, K. S., & Zimmerman, D. H. (2022) · Medical Research Archives · doi:10.18103/mra.v10i7.2910
Insight into the Autoantibody Landscape in Rheumatoid Arthritis for Companion Diagnostics
Poulsen, T. B. G. (2021) · doi:10.54337/aau468601011
TSLC-1 and STAT-3 Expression and Its Implication in Cervical Adenocarcinoma
Musse, S. Y. (2022) · Journal of Gynecology and Obstetrics · doi:10.11648/j.jgo.20221002.18
The JAK–STAT–SOCS Signaling Cascade
Murphy, J. M., Babon, J. J., Nicola, N. A., & Nicholson, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30016-5
Immunodeficiency, Leukemia, and Lymphoma
Srinivasan, A., Sinha, A. A., & Frazer, J. K. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_82
Bcl-2, JAK and mTOR Inhibitors
Mueller, N. J., & Burkhard, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-11363-5_16
Gaudichaudione H inhibits Herpes Simplex Virus-1 replication by regulating cellular nuclear factor-κB in an interferon-γ-inde-pendent mannerPreprint
Feng, J., Tang, Y., Fu, W., & Xu, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.523065
The significance of M1 ‐polarized CD163 + macrophages in acute graft‐versus‐host disease ( GVHD ): Possible mechanisms of GVHD in the development of skin lesions
Muto, Y., Fujimura, T., Kambayashi, Y., Ohuchi, K., Lyu, C., Terui, H., Mizuashi, M., Aiba, S., & Asano, Y. (2023) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12304
Genetic Diseases and Invasive Infections in Infants 100 Days or Younger
Zhu, T., Bei, F., He, R., Gong, X., Chen, Y., Yin, Z., Wang, J., Sun, Y., & Zhang, Y. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003939
Design, Synthesis and Bioactivity Study of Marine Alkaloid Neobacillamide—A Derivatives
Wang, J., Li, M., Zhang, X., Zhang, Z., Liu, Y., Liu, L., Yin, R., & Jiang, T. (2023) · Journal of Ocean University of China · doi:10.1007/s11802-023-5381-3
Avaliação de quimiocinas circulantes em pacientes com câncer de mama, o ardiloso luminal b e as misteriosas quimiocinas
Araújo, R. (2023) · doi:10.14393/ufu.te.2022.586
JAK inhibitors for the treatment of inflammatory bowel disease
Ma, C. (2023) · Canadian IBD Today · doi:10.58931/cibdt.2023.115
FeCl3-Catalyzed Cross-Coupling for Improving the Synthesis of Upadacitinib
Li, Z., Shi, C., Xiang, S., Liu, C., & Zheng, X. (2023) · Journal of the Brazilian Chemical Society · doi:10.21577/0103-5053.20230165
De Novo Mutations Promote Inflammation in Children with Stat3 Gain-of-Functionsyndrome by Affecting Il-1β ExpressionPreprint
Chen, J., Li, Y., Zhou, Z., Jiang, X., Bi, X., Yang, M., & Zhao, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4776231
Additional file 3 of Development of a prognostic signature for esophageal cancer based on nine immune related genes
Zhang, Z., Chen, C., Fang, Y., Li, S., Wang, X., Lei, S., Zhou, G., & Ye, J. (2021) · Figshare · doi:10.6084/m9.figshare.13719354
De novo mutations promote inflammation in children with STAT3 gain-of-function syndrome by affecting IL-1β expressionPreprint
Chen, J., Li, Y., Jiang, X.-M., Bi, X., Yang, M., Zhou, Z., & Zhao, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4181172/v1
The Interaction between CD48 with Ligands and the Research Progress in Diseases
詹, 雁. (2024) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2024.142032
A term infant with severe hypereosinophilia secondary to CMV infection and the STAT1 gene mutation: a case report
Salah, S., Alshanbari, S. N., & Masmali, H. M. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04846-4
De novo mutations promote inflammation in children with STAT3 gain-of-function syndrome by affecting IL-1β expression
Chen, J., Li, Y., Zhou, Z., Jiang, X.-M., Bi, X., Yang, M., & Zhao, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112755
Molecular Targeted Therapies in Systemic Autoimmune Diseases
Tanaka, Y. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_29-1
Inflammation in Carcinogenesis
Kuckhahn, O. K., & Schwertfeger, K. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00169-8
Molecular Targeted Therapies in Systemic Autoimmune Diseases
Tanaka, Y. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_29
Cancer signaling pathways: targets and treatment
Vishnusai, B., Sharma, R., Parihar, V. K., & Kumar, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95258-3.00006-0
Exploring mimosamycin as a Janus kinase 2 inhibitor: A combined computational and experimental investigation
Sanachai, K., Hengphasatporn, K., Chamni, S., Suwanborirux, K., Mahalapbutr, P., Shigeta, Y., Seetaha, S., Choowongkomon, K., & Rungrotmongkol, T. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108346
SAR317461 Inhibit JAK2/STAT3 Phosphorylation for Enhanced Anti-leukemia Activity
Yang, X.-Y., Wang, Y., Zhang, L., Pang, S.-L., Li, X., Wang, P., Ma, R., Ma, Y., & Song, C.-G. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02004-z
Role of JAK-STAT signaling pathway in recurrent pregnancy loss
Zubair, S., Khan, N. A., Sharma, S., Khera, N., & Rashid, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13617-7.00013-x
Effective virtual screening strategy toward JAK3 covalent inhibitors: combining multi‑conformational consensus calculation with covalent docking
Zhu, J., Qiu, G., Xu, L., Cai, Y., Chen, Y., & Jin, J. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11329-w
Introduction to curcumin as a therapeutic agent
Ahmed, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29196-8.00003-3
Computational Estimation of Compounds Isolated from Asarum geophilum as Potential Inhibitors of Janus Kinase 2 (JAK2) Protein
Do, T. L., Tuan, N. T., Hưng, N. A., Quân, P. M., & Minh, P. T. H. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i8.9
The CDK9-targeting degrader PO-8 alleviates LPS-induced inflammation by inhibiting JAK-STAT signaling in vitro and in vivo
Ao, M., Wang, X., Cao, Y., Li, X., Zhang, Y.-X., Li, J.-Y., Li, M., Huang, M., Qiu, Y., Hu, H.-Y., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117341
Jak-STAT Signaling Pathways
Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00508-1
Momelotinib: a new frontier as a JAK1 and JAK2 inhibitor in hematological disorders
Mohite, P. B., Bharati, D., Gohri, V., & Puri, A. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00027-5
Computational insights into insect-derived semiochemicals from Formicidae family as potential JAK1 inhibitors: Virtual screening and molecular dynamics studies
Borthakur, S., Sarmah, P., Saikia, M., Dhakal, R., Gupta, D. D., Kalita, J., Verma, J. S., & Dutta, P. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108730
Function‐driven design of a surrogate interleukin‐2 receptor ligand
Tang, Z., Cheng, Z., Li, T., Wang, F., Zhang, L. Q., He, X., Liu, L., Wang, W., Liang, A., & Yang, G. (2025) · FEBS Letters · doi:10.1002/1873-3468.70249
Additional file 2 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829714
Additional file 1 of Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment
Wood, S. L., Branch, J., Vasquez, P., DeGuzman, M., Brown, A. L., Sagcal‐Gironella, A. C. P., Singla, S., Ramirez, A. A., & Vogel, T. P. (2024) · Figshare · doi:10.6084/m9.figshare.25330838
Additional file 3 of Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Emery, P., Tanaka, Y., Cardillo, T. E., Schlichting, D. E., Rooney, T. P., Beattie, S., Helt, C. C., & Smolen, J. S. (2020) · Figshare · doi:10.6084/m9.figshare.12316028
Additional file 1 of Development of a prognostic signature for esophageal cancer based on nine immune related genes
Zhang, Z., Chen, C., Fang, Y., Li, S., Wang, X., Lei, S., Zhou, G., & Ye, J. (2021) · Figshare · doi:10.6084/m9.figshare.13719348
Additional file 6 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829726
Additional file 14 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829708
Additional file 2 of Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Emery, P., Tanaka, Y., Cardillo, T. E., Schlichting, D. E., Rooney, T. P., Beattie, S., Helt, C. C., & Smolen, J. S. (2020) · Figshare · doi:10.6084/m9.figshare.12316019
Additional file 2 of Development of a prognostic signature for esophageal cancer based on nine immune related genes
Zhang, Z., Chen, C., Fang, Y., Li, S., Wang, X., Lei, S., Zhou, G., & Ye, J. (2021) · Figshare · doi:10.6084/m9.figshare.13719351
Additional file 1 of Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Emery, P., Tanaka, Y., Cardillo, T. E., Schlichting, D. E., Rooney, T. P., Beattie, S., Helt, C. C., & Smolen, J. S. (2020) · Figshare · doi:10.6084/m9.figshare.12316016
Additional file 2 of Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment
Wood, S. L., Branch, J., Vasquez, P., DeGuzman, M., Brown, A. L., Sagcal‐Gironella, A. C. P., Singla, S., Ramirez, A. A., & Vogel, T. P. (2024) · Figshare · doi:10.6084/m9.figshare.25330888
Additional file 3 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829717
Additional file 12 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829702
Additional file 1 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829711
Additional file 5 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829723
Additional file 9 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829738
Additional file 13 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829705
Additional file 11 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829699
Additional file 10 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829696
Additional file 7 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829729
Additional file 8 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829735
Additional file 4 of Noncanonical Wnt5a signaling regulates tendon stem/progenitor cells senescence
Chen, M., Li, Y., Xiao, L., Dai, G., Lu, P., & Rui, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829720
Pristimerin Suppresses STAT3 Signaling in Colorectal Cancer Cells by Targeting JAK2: In Silico and In Vitro Evidence
Yousef, B. A., Elhafiz, M., Ahmedani, E. I., Ismail, M., Bahafi, A. A., El‐Moselhy, M. A., & Saleh, M. A. (2025) · Oriental Journal Of Chemistry · doi:10.13005/ojc/410609
Janus Kinase Inhibitors
Bubna, A. (2025) · Springer eBooks · doi:10.1007/978-981-95-3795-2_2
TMEM205 promotes M2-like macrophage polarization and advances the progression of triple-negative breast cancer
Zhang, Y., Peng, J., Ma, T., Liu, X. X., Liu, J., Zhou, Q., & Wang, H. (2026) · Breast Cancer Research and Treatment · doi:10.1007/s10549-026-07911-x
Molecular Targeted Therapy for Chronic Non-Bacterial Mastitis: New Insights into Pathophysiology and Therapeutic Strategies
Xuan, Z., Zheng, K., Zhang, D., & Wei, H. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s580664 · Cited by 1
Protective effects of the selective JAK2/3 inhibitor AG490 against ulcer formation following cutaneous ischemia-reperfusion injury
Saito, S., Uchiyama, A., Araki, T., Inoue, Y., Ohtaka, M., Kosaka, K., Shuto, T., Ida, A., Yokoyama, Y., Ogino, S., et al. (2026) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2026.03.004
Approches thérapeutiques métaboliques et immunologiques des leucémies aiguës myéloïdes
Venton, G. (2016) · theses.fr (ABES) · doi:10.70675/2b894d94zf035z47d5zbf3dzcf524b6bbe5a
Clinical and molecular characterisation of type I interferonopathies
Melki, I. (2017) · theses.fr (ABES) · doi:10.70675/56be76a9z1a05z4438zabf7zaf769da7e2fc
Clinical and molecular characterisation of the type I interferonopathies and approaches to therapy
Frémond, M. (2018) · theses.fr (ABES) · doi:10.70675/a5e8252azb7f7z4f38zb08dzd8e8c7df0db2
Sélection et caractérisation d’aptamères oligonucléotidiques régulateurs de la protéine STAT5B, impliquée dans les leucémies
Loussouarn, C. (2014) · theses.fr (ABES) · doi:10.70675/f8881714z8e9fz4edezbc86z71281d76d5fb
Pathophysiology of cardiovascular events in Bcr/Abl-negative myeloproliferative neoplasms
Poisson, J. (2018) · theses.fr (ABES) · doi:10.70675/d71df373z8cc7z41c1z9896zab996bc5b48e
Les astrocytes réactifs, des partenaires anti-agrégants dans la maladie de Huntington : identification des mécanismes impliqués dans le dialogue neurone-astrocyte
Abjean, L. (2019) · theses.fr (ABES) · doi:10.70675/f664e003zf93fz467eza6a3z3d953eaffe4e
Inhibition of the tyrosine phosphatase protein PTPN2 by etoposide quinone and functional characterization of a pathological mutant
Nian, Q. (2019) · doi:10.70675/652fef5ez49f0z4ba9za934z6e485d7c3e1d
Chromatin Disorganization as a Regulator of Irradiation-Induced L1Md Expression and Hematopoietic Stem Cell Function
Pelinski, Y. (2020) · theses.fr (ABES) · doi:10.70675/70a73ff4z5e24z4244z8e55z410230ebf53c
Effet de l'inhibition ciblée des interférons de type I sur l'endothélium vasculaire au cours du sepsis
Clère-Jehl, R. (2020) · theses.fr (ABES) · doi:10.70675/a65a57a6ze1d1z47baz8fa5zabef17722df4
Immunology and Autoimmunity: Current Concepts and Clinical Implications
Ahmed, N., & Humaira, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-12937-6_1
Physiopathological mechanisms leading to two congenital thrombocytopenias, congenital amegakaryocytic thrombocytopenia (CAMT) and thrombocytopenia 2 (THC2)
Basso‐Valentina, F. (2021) · theses.fr (ABES) · doi:10.70675/a56f0f8bz6734z40fbzb826z92de65ef65ce
Investigating the molecular signature of reactive astrocytes mediated by the JAK2- STAT3 pathway using different omics : transcriptomics and proteomics insights
Riquelme‐Perez, M. (2023) · theses.fr (ABES) · doi:10.70675/72aad0d8z36a8z4a7azb1eaze65fa79463da
Investigating the molecular mechanism of selective inhibition of JAK1/TYK2 by SOCS1/SOCS3 using molecular dynamics simulations
Zhai, X., Li, Y., Yang, Y.-B., Liu, Y., & Chu, H. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp00092d
Extensive cutaneous viral warts during JAK inhibitor therapy for atopic dermatitis
Hilewitz, D., Leshem, Y. A., Dodiuk‐Gad, R. P., Mandola, A. B., Gooderham, M., & Greenberger, S. (2026) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.70418
JAK/STAT signaling in liver disease: a therapeutic target or a context-dependent double-edged sword?
Wang, T., Li, L., & Lu, J. J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08135-9
Ensemble threshold Boolean modeling reveals robust attractors and regulatory drivers in pediatric leukemia
Kittaneh, H., Castiglione, F., Liso, A., & Jarrah, A. S. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111714
Harnessing patient health data to benefit individuals and advance research: a focus on rheumatoid arthritis – a narrative review
Schneider, M., Griffin, A. C., Follis, S., Tamang, S. R., Hernandez‐Boussard, T., & Hong, J. (2026) · BMJ Digital Health & AI · doi:10.1136/bmjdh-2026-000070
The theory of tumor immuno-ecodynamics
Chen, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823415
Case Report: A case series of using whole exome sequencing to detect novel variants in Vietnamese patients with inborn errors of immunity
Lien, N. T. K., Tung, N. V., Huong, L. T. M., Anh, N. T. V., Phuong, N. T., Điền, T. M., Hiển, N. T., Tao, N. T., & Hoang, N. H. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1818952
Identification of BMX as a Potential Biomarker for Rheumatoid Arthritis Based on WGCNA, Machine Learning, and Experimental Validation
Huang, X., Cai, X., Yan, Z., Wu, X., Chen, X., & Xiao, J. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2674702

Authors: O'Shea, J. J., Holland, S. M., & Staudt, L. M.
Affiliations: National Institute of Allergy and Infectious Diseases (US)
National Institutes of Health (US)
ORCID: Holland, Steven M.
Staudt, Louis M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2013-01-10
Volume: 368
Issue: 2
Pages: 161-170
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1202117
PMC: PMC7604876
OpenAlex: W2040002852
Cited by: 927
References: 101
Citations by year: 2026: 47 · 2025: 61 · 2024: 64 · 2023: 76 · 2022: 79 · 2021: 91 · 2020: 78 · 2019: 60 · 2018: 44 · 2017: 70 · 2016: 66 · 2015: 69 · 2014: 67 · 2013: 52
FWCI: 8.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (Z01SC004024)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (ZIAAR041106)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: JAK/STAT signaling, cytokine signaling, immunodeficiency, cancer, immune regulation, JAK inhibitors, STAT inhibitors, targeted therapy
MeSH terms: Hematologic Diseases, Humans, Immunologic Deficiency Syndromes, Mutation, Neoplasms, Signal Transduction, Cytokines, STAT Transcription Factors, Janus Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks